2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow NVR 3-778: new trials by email Literature Review of NVR 3-778 trials Research Report on NVR 3-778
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers AL-3778, Entecavir, Tenofovir disoproxil fumarate - Hepatitis B, Chronic Hepatitis B | Phase 1 | Terminated | Alios Biopharma Inc. | 54 | 2017-01-31 | 2017-10-16 |
| Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients NVR 3-778, Placebo for NVR 3-778, Pegasys - Chronic Hepatitis B | Phase 1 | Completed | Novira Therapeutics, Inc. | 58 | 2015-01-31 | 2017-10-18 |
| Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients NVR 3-778, Placebo for NVR 3-778, Pegasys - Chronic Hepatitis B | Phase 1 | Completed | Novira Therapeutics, Inc. | 55 | 2014-04-30 | 2017-10-18 |
Hepatitis B (3) · Hepatitis B, Chronic (3)
Novira Therapeutics, Inc. (2) · Alios Biopharma Inc. (1)
New Zealand (2) · China (1) · Singapore (1) · South Korea (1) · Taiwan (1) · United States (1)